We work to help our clients achieve results that improve health systems, services, and, ultimately, people’s lives.
JSI is supporting the preparations and/or national introduction of the Human Papilloma Virus (HPV) vaccine in Cameroon, Kenya, and Malawi. HPV is linked to cervical cancer and vaccination efforts focus on reaching pre-adolescent/adolescent girls (i.e. between 9-14 years old). Through funding from Gavi, the Vaccine Alliance, JSI, in close collaboration with the Ministry of Health,…
Despite reported improved coverage rates over the past several years, Mozambique still experiences wide inequities in coverage across and within provinces, and the improvements have stagnated recently. Additionally, significant inconsistencies in coverage rates exist between administrative data, WUENIC estimates, and the recent household Malaria, HIV/AIDS, and Immunisation Indicator Survey (IMASIDA) which cast doubt on immunization…
JSI leads the external evaluation of George Washington University’s (GWU) Atlantic Fellows for Health Equity (AFHE) Fellowship Program during the initial phase of its operation as part of the Atlantic Philanthropies' (Atlantic) Atlantic Fellows Program. JSI’s external evaluation assesses GWU’s institutional capacities position it to fulfill its goals, tracks program effectiveness over time, and informs…
JSI is working to address the challenge of low immunization coverage in urban areas of Indonesia by gaining a nuanced understanding of factors that affect the demand for, barriers of access to, and use of immunization services. JSI is supporting the development of a sustainable strategic action plan in collaboration with Universitas Indonesia. JSI aims…
Through funding from Gavi, the Vaccine Alliance, JSI provides technical assistance to the Government of Niger's Immunization Department (DI in French) to support and strengthen immunization program activities and supply chain management. JSI has been supporting the Republic of Niger's priority activities since 2013, in response to technical assistance needs identified by the MOH and…
Through funding from Gavi, the Vaccine Alliance, JSI is supporting the preparations and/or national introduction of the Human Papilloma Virus (HPV) vaccine in Zimbabwe, Tanzania, and Malawi. HPV is linked to cervical cancer and vaccination efforts focus on reaching pre-adolescent/adolescent girls (i.e. between 9-14 years old). JSI, in close collaboration with the Ministry of Health,…
Since 2013, JSI has leveraged its over 30 years of leadership in health supply chain management to monitor various family planning (FP) pharmaceutical agreements negotiated by the Bill & Melinda Gates Foundation (the Foundation) with manufacturers. These agreements were enacted under the Family Planning 2020 initiative (FP2020) to reduce the public sector purchase price of…
In Mozambique, the U.S. Centers for Disease Control and Prevention (CDC) is funding JSI to build the capacity of the country’s National HIV and AIDS Council (CNCS) in social and behavior change communication (SBCC). Specifically, JSI will support the CNCS to strengthen the national HIV and AIDS communication strategy, develop a monitoring and evaluation tool…
JSI and its partners propose to answer a research question that is key to maximizing the role that markets can play to support improved nutrition, especially in the first 1000 days: Can market-centered interventions successfully increase the intake of animal-sourced foods (ASFs) in children 6 – 23 months of age in Tigray, Ethiopia? Leveraging the…
Under the Partnerships Plus project, JSI is supporting programs that are improving the health of their communities, especially related to children in adversity and habilitation/rehabilitation. JSI is providing grants management and capacity-building expertise to support local organizations and ultimately improve access to early childhood services, protective family care, and support for inclusion and disability-related challenges. Partnerships…
We strive to build lasting relationships to produce better health outcomes for all.
